Cargando…

Predictors of recurrence free survival for patients with stage II and III colon cancer

BACKGROUND: The aim of this study was to evaluate clinico-pathologic specific predictors of recurrence for stage II/III disease. Improving recurrence prediction for resected stage II/III colon cancer patients could alter surveillance strategies, providing opportunities for more informed use of chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsikitis, Vassiliki L, Larson, David W, Huebner, Marianne, Lohse, Christine M, Thompson, Patricia A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029910/ https://www.ncbi.nlm.nih.gov/pubmed/24886281 http://dx.doi.org/10.1186/1471-2407-14-336

Ejemplares similares

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Recurrence-Free Survival Outcomes Based on Novel Classification Combining Lymphovascular Invasion, Perineural Invasion, and T4 Status in Stage II–III Colon Cancer
por: Kang, Jae Hyun, et al.
Publicado: (2022)

Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer
por: Liu, Chang, et al.
Publicado: (2016)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
por: Croese, Alex, et al.
Publicado: (2021)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

A prognostic nomogram for predicting recurrence-free survival of stage I–III colon cancer based on immune-infiltrating Treg-related genes
por: Xu, Longwen, et al.
Publicado: (2023)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer
por: Sebio, Ana, et al.
Publicado: (2015)

A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer
por: Ma, Jian, et al.
Publicado: (2019)

Trends of Incidence and Survival of Gastrointestinal Neuroendocrine Tumors in the United States: A Seer Analysis
por: Tsikitis, Vassiliki L., et al.
Publicado: (2012)

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
por: Taal, B G, et al.
Publicado: (2001)

Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer
por: Ganenko, Denis, et al.
Publicado: (2018)

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
por: Mandalá, Mario, et al.
Publicado: (2021)

A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer
por: Ruan, Ji
Publicado: (2019)

The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection
por: Nakamura, Yasuyuki, et al.
Publicado: (2021)

Expressions of 10 genes as candidate predictors of recurrence in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy
por: Kumamoto, Kensuke, et al.
Publicado: (2019)

Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
por: Yan, D-W, et al.
Publicado: (2010)

Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
por: Shanmugam, Chandrakumar, et al.
Publicado: (2011)

Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients
por: Giampieri, Riccardo, et al.
Publicado: (2013)

A machine learning-based prognostic predictor for stage III colon cancer
por: Jiang, Dan, et al.
Publicado: (2020)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

Biological predictors of survival in stage II colorectal cancer
por: UEDA, YOSHITAKE, et al.
Publicado: (2013)

Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis
por: Boyne, Devon J., et al.
Publicado: (2019)

Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study
por: Lu, Jun, et al.
Publicado: (2020)

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2020)

Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
por: Lee, Seohyuk, et al.
Publicado: (2021)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)

Prognostic impact of mutation profiling in patients with stage II and III colon cancer
por: Shen, Yinchen, et al.
Publicado: (2016)

Prognostic significance of primary tumor localization in stage II and III colon cancer
por: Sakin, Abdullah, et al.
Publicado: (2018)

Wnt5a expression and prognosis in stage II–III colon cancer
por: Lund, Cecilia Margareta, et al.
Publicado: (2020)

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer
por: Xu, Yansong, et al.
Publicado: (2020)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients
por: Gast, Marie-Christine W, et al.
Publicado: (2008)

Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
por: Sperlich, Andreas, et al.
Publicado: (2018)

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
por: Dienstmann, R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dre8qp06ti4vq8m5gvp70flrh1